Vice President Biopharma And Dna Production
CurrentWas a core team leader in establishing and positioning Applied DNA Sciences' unique large-scale PCR DNA production platform into the diagnostic and therapeutic markets. -Led business development by recruiting key customers to evaluate our product for their nucleic acid-based therapy programs, including DNA and RNA vaccines and CAR T therapies. -Led the internal design, production, and quantification teams to produce the specific amplicons for our customers to the required specification. -Drove joint development projects, based on our linear DNA with key partners that resulted in pre-clinical and clinical programs, including a COVID-19 liner DNA vaccine trial involving Ferrets at Cornell University -Co-Author on the publication of a manuscript detailing a preclinical study regarding the use of t LinearDNA™ vaccines used for cancer immunotherapy.Key Contributor in the investment, installation, implementation, and support for COVID-19 diagnostic and surveillance labs. -Purchased and managed the installation of Hamilton STAR and STARlet liquid handlers for automated processing of COVID-19 samples. -Orchestrated BSl2 enclosures for the Hamilton to accept live virus in order to maximize sample throughput. -Evaluated and implemented a number of RNA extraction methodologies utilizing Hamilton and ThermoFisher products to yield the most cost-effective solution -Supported the deployment of the automated solution at Applied DNA Sciences Clinical Lab (ADCL) as well as Stony Brook University Hospital (SBUH) where our solution was used to monitor COVID-19 across the hospital and university staff and students -Managed the supply chain of consumables for both ADCL as well as SBUH